A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

Clinical trial NCT05744401 · TERMINATED

Trial details

NCT number: NCT05744401
Sponsor: Alector Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2023-01-04
Primary completion: 2025-01-31
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.